Mersana Therapeutics, Inc. (69) | Business Operations (8)

Browse by Subcategory

Collaboration Agreements (6 contracts)
Sales Agreements (2)

Recent Contracts

Amendment 3 to the Collaboration and Commercial License Agreement, dated February 28, 2017, by and between Mersana Therapeutics, Inc. and Merck KGaA (Filed With SEC on May 9, 2023)
Amendment 2 to the Collaboration and Commercial License Agreement, dated August 12, 2016, by and between Mersana Therapeutics, Inc. and Merck KGaA (Filed With SEC on May 9, 2023)
Amendment 1 to the Collaboration and Commercial License Agreement, dated June 1, 2016, by and between Mersana Therapeutics, Inc. and Merck KGaA (Filed With SEC on May 9, 2023)
Collaboration and Commercial License Agreement, dated June 23, 2014, by and between Mersana Therapeutics, Inc. and Merck KGaA (Filed With SEC on May 9, 2023)
Collaboration and Commercial License Agreement, dated December 22, 2022, between Mersana Therapeutics, Inc. and Ares Trading S.A (Filed With SEC on February 28, 2023)
Sales Agreement dated November 7, 2022 by and between the Company and Cowen and Company, LLC (Filed With SEC on November 7, 2022)
Research Collaboration and License Agreement, dated February 2, 2022, between the Company and Janssen Biotech, Inc (Filed With SEC on May 9, 2022)
Sales Agreement dated February 28, 2022 by and between the Company and Cowen and Company, LLC (Filed With SEC on February 28, 2022)